Short Interest in CanSino Biologics Inc. (OTCMKTS:CASBF) Decreases By 8.2%

CanSino Biologics Inc. (OTCMKTS:CASBF) was the target of a significant decline in short interest in the month of January. As of January 31st, there was short interest totalling 13,400 shares, a decline of 8.2% from the January 15th total of 14,600 shares. Based on an average daily trading volume, of 100 shares, the short-interest ratio is presently 134.0 days.

CanSino Biologics Stock Performance

Shares of CASBF stock opened at C$3.37 on Monday. The stock has a 50 day simple moving average of C$3.71 and a 200 day simple moving average of C$3.27. CanSino Biologics has a 1 year low of C$1.86 and a 1 year high of C$4.35.

CanSino Biologics Company Profile

CanSino Biologics Inc develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N.